Hemorrhagic Cystitis Clinical Trial
Official title:
A Multicenter, Dose-Ranging Trial Evaluating the Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis
The purpose of this study is to assess the safety and tolerability of three doses of LP-10 (intravesical tacrolimus). Twelve subjects meeting the inclusion and exclusion criteria will be enrolled and treated in a prospective and multi-center trial with LP-10. The proposed trial will recruit 12 subjects in a dose-escalation trial where 4 subjects will be allocated into each one of three groups.
This is a multi-center, dose-ranging study including male and female subjects with refractory moderate to severe hemorrhagic cystitis as determined by a physician. A total of up to 12 subjects are anticipated and will be enrolled in study sites in the United States. Enrollment is expected to be completed within one year of initiating the study. The proposed trial will recruit 12 subjects in a dose-escalation trial where 4 subjects will be allocated into each one of three groups. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02172963 -
A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis
|
Phase 1/Phase 2 | |
Recruiting |
NCT04696666 -
Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis
|
N/A | |
Recruiting |
NCT05348239 -
Chlorophyllin Tablets for Urinary Bleeding Following Radiation Therapy for Cancers of Pelvic Organs
|
Phase 2 | |
Recruiting |
NCT02174536 -
A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis
|
Phase 2 | |
Terminated |
NCT04390113 -
Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)
|
Phase 3 | |
Not yet recruiting |
NCT06241274 -
Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
|
N/A | |
Not yet recruiting |
NCT06198517 -
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
|
N/A | |
Recruiting |
NCT05726786 -
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
|
Phase 3 |